United States v. Parkison

417 F. Supp. 730, 1 Fed. R. Serv. 1175
CourtDistrict Court, E.D. Wisconsin
DecidedJune 30, 1976
Docket75-CR-73
StatusPublished
Cited by4 cases

This text of 417 F. Supp. 730 (United States v. Parkison) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Parkison, 417 F. Supp. 730, 1 Fed. R. Serv. 1175 (E.D. Wis. 1976).

Opinion

MEMORANDUM AND ORDER

WARREN, District Judge.

Defendant was indicted and subsequently convicted of possession with intent to distribute and distribution of approximately 1,700 dosage units of lysergic acid diethylamide in violation of section 401 of the Comprehensive Drug Abuse Prevention and Control Act of 1970, 21 U.S.C. § 841(a)(1). Post-trial motions have been filed with the Court seeking a judgment of acquittal pursuant to rule 29 or, in lieu thereof, a new trial pursuant to rule 33 of the Federal Rules of Criminal Procedure. After reviewing the briefs both in support of and in opposition to said motions and having been duly advised of the premises thereto, the Court is of the opinion that they must all be denied in accordance with the following memorandum opinion.

I.

With regard to the motion for judgment of acquittal, the defendant relies upon the assertion that the proof offered at trial was at variance with the charges in the indictment. The variance, it is argued, affects substantial rights of the defendant and warrants a judgment of acquittal. See, Berger v. United States, 295 U.S. 78, 55 S.Ct. 629, 79 L.Ed. 1314 (1935). More specifically, the variance is claimed to have resulted in the deprivation of defendant’s right to be tried on an indictment returned by a grand jury and his right to notice of the charges against him.

During the trial, it became evident that current Government testing procedures were unable to distinguish between lysergic acid diethylamide and its salts, isomers or salts of isomers. Defendant’s expert witness testified that adequate testing procedures were available but such were not utilized by the Government and that with regard to the procedures employed, the Government was unable to distinguish between lysergic acid diethylamide and lysergic acid diethylamide tartrate or Lampa. The latter two substances are respectively a salt and an isomer of lysergic acid diethylamide.

*733 As a result of the testing deficiencies described above, the defendant argues that the Government in effect has not met its burden of proof as to the identity of the substance allegedly distributed. It is argued that the proof is therefore at variance with the indictment which charges the defendant with possession with intent to distribute and distribution of only the substance lysergic acid diethylamide and not its salt or isomer; and, accordingly, the defendant is entitled to a judgment of acquittal.

The Government relies upon United States v. Moser, 509 F.2d 1089 (7th Cir. 1975) which rejected a variance argument under 21 U.S.C. § 841(a)(1) in a distinguishable factual context.

Defendants’ variance argument is without merit. To require a reversal, a variance between the indictment and the proof must affect the substantial rights of the defendant. Berger v. United States, 295 U.S. 78, 82, 55 S.Ct. 629, 79 L.Ed. 1314 (1935); Cromer v. United States, 78 U.S.App.D.C. 400, 142 F.2d 697, 698 (1944), cert. denied, 322 U.S. 760, 64 S.Ct. 1274, 88 L.Ed. 1588 (1944). Here defendants’ rights were not substantially affected if the evidence shows that they were aware of the nature of the substance they possessed. 509 F.2d at 1092.

It is the Government’s position that the technical nature of the variance involved in the case at bar had no effect on the rights of the defendant. See, also, United States v. Van Buren, 513 F.2d 1327 (10th Cir.), cert. denied, 421 U.S. 1002, 95 S.Ct. 2402, 44 L.Ed.2d 670 (1975).

The indictment reads in pertinent part as follows:

That on or about March 6, 1975, at Milwaukee in the State and Eastern District of Wisconsin,
ROBERT PARKISON
did knowingly and intentionally possess, with intent to distribute, and did distribute approximately 1,700 dosage units of lysergic acid di-ethylamide, a Schedule I Controlled Substance .

The Government’s evidence revealed that the defendant possessed with intent to distribute and did distribute the substance of lysergic acid diethylamide or one of its chemical derivatives. The Court is of the opinion that the variance is at most a highly technical one known only to those sophisticated in the ways of chemistry. It would approach the absurd to suggest that Parkison had no notice of the charges against him because the substance was lysergic acid diethylamide tartrate rather than lysergic acid diethylamide. The Court therefore finds little merit in defendant’s contention that he was deprived of the right to notice of the charges against him.

Moreover, the Court is not convinced that there is a variance in the first place. Defendant’s variance argument is predicated upon the theory that the free base is distinguishable from its salt, isomer, or salt of an isomer. There is no doubt that the free base is distinguishable from its salt in the ultimate chemical sense but the proscription in the eyes of the law runs to the free base or one of its chemical derivatives. Section 812 of Title 21 reads in pertinent part:

§ 812. Schedules of controlled substances—Establishment
******
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible with the specific chemical designation : ******
(9) Lysergic acid diethylamide. (Emphasis added).

Whether the term used is “controlled substance” or “chemical designation,” it is clear that it is the chemical family of a particular drug that is proscribed. In this sense the chemical designation, lysergic acid diethylamide, includes the base substance and any material, com *734 pound, mixture or preparation which contains -any quantity of the base substance or which contains any of its salts, isomers, and salts of isomers.

The indictment charges the defendant-with possession with intent to distribute and distribution of “1,700 dosage units of lysergic acid di-ethylamide, a Schedule I Controlled Substance . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Avance R. Allen
629 F.2d 51 (D.C. Circuit, 1980)
People v. Beatty
259 N.W.2d 892 (Michigan Court of Appeals, 1977)

Cite This Page — Counsel Stack

Bluebook (online)
417 F. Supp. 730, 1 Fed. R. Serv. 1175, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-parkison-wied-1976.